Repurposing β-Lactams for the Treatment of <i>Mycobacterium kansasii</i> Infections: An In Vitro Study

Repurposing β-Lactams for the Treatment of <i>Mycobacterium kansasii</i> Infections: An In Vitro Study

<i>Mycobacterium kansasii</i> (<i>Mkn</i>) causes tuberculosis-like lung infection in both immunocompetent and immunocompromised patients. Current standard therapy against <i>Mkn</i> infection is lengthy and difficult to adhere to. Although β-lactams are the most...

Full description

Bibliographic Details
Main Authors: Lara Muñoz-Muñoz, José A. Aínsa, Santiago Ramón-García
Format: Article
Language:English
Published: MDPI AG 2023-02-01
Series:Antibiotics
Subjects:
nontuberculous mycobacteria
<i>Mycobacterium kansasii</i>
repurposing
β-lactam combinations
amoxicillin–clavulanate
cefadroxil
Online Access:https://www.mdpi.com/2079-6382/12/2/335

Similar Items

Similar Items